Belly fat raises health risks like heart disease and diabetes. Reduce it with a balanced diet, exercise, stress management, better sleep, and tracking progress for long-term results.
Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.